Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine, successfully developing a vaccine candidate that could help the immune system ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Just in the past week, generative AI company Abridge announced deals with Mayo Clinic, Duke Health, and Johns Hopkins ...

Kate Middleton made a surprise visit to the Royal Marsden Hospital where she received cancer treatment, following her ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

The hormone changes that occur during perimenopause and menopause can cause mood swings, anxiety, depression, but also ...

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

These contributions reflect the community’s strong support for Duke-NUS’ leading role in medical innovation and education.

Duke Health in Durham, N.C., has selected Abridge as its generative AI partner to capture clinical conversations.